Crinetics Pharmaceuticals, Inc. (CRNX) Social Stream

Crinetics Pharmaceuticals, Inc. (CRNX): $16.23

-0.73 (-4.30%)

POWR Rating

Component Grades













Featured Post From StockTwits About CRNX

$CRNX Crinetics Pharmaceuticals Inc The network has predicted the market value of this company is in line with fundamentals in the short term and has no clear long term directional perspective
intratio, published April 26, 2021

What Else are CRNX Traders Talking About?

Other tickers frequently mentioned alongside CRNX are CRTX, TYHT and GRNQ.

Other Notable StockTweets About CRNX

Crinetics Pharmaceuticals Inc The AI lets us believe that this stock price will be stable in the short term and will have a negative trend in the upcoming months $CRNX

intratio, published April 13, 2021

Thursday's Top Market Hour Runners to be watched for potentially more upside continuation tomorrow - Brought to you by team Arcadia:

1. $cga +9.14%
2. $CRTX +8.99%
3. $TYHT +8.98%
4. $CRNX +8.88%
5. $GRNQ +8.8.6%
P.S. Some of these plays dropped a little in the afternoon because they have been up so much, doesn't mean they don't have more upside.

Team Arcadia is super friendly community, currently up 837.2% in closed positions in the last 30 trading days. Up 188.9% on one of the recent closed position BCLI, CNSP and AGEN (screenshot below).

If you don't believe me, all my trades are recorded, live, and dated in my channel, feel free to come check them out.

Click the link in my profile bio to join our friendly and helpful community, and get the exact same entries and exits as me!

ArcValueTrade, published April 8, 2021

$CRNX Form 8-K: Results of Operations and Financial Condition. On March 30, 2021, Crinetics Pharmaceuticals issued a press release reporting its financial results for the quarter and fiscal year ended..

Newsfilter, published March 30, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5449 seconds.